Table 4.
Without PERSARC, N (%) | With PERSARC, N (%) | |
---|---|---|
Neoadjuvant radiotherapy | ||
Surgery R0 | 10 (27.7%) | 25 (69.4%) |
Surgery R1 | 13 (36.1%) | 6 (16.7%) |
Surgery R2 | 2 (5.6%) | 0 (0.0%) |
| ||
Surgery | ||
Amputation | 5 (13.8%) | 1 (2.8%) |
R0 | 2 (5.6%) | 1 (2.8%) |
R1 | 1 (2.8%) | 3 (8.3%) |
R2 | 2 (5.6%) | 0 (0.0%) |
| ||
Adjuvant radiotherapy | ||
Surgery R0 | 0 (0.0%) | 0 (0.0%) |
Surgery R1 | 1 (2.8%) | 0 (0.0%) |
Surgery R2 | 0 (0.0%) | 0 (0.0%) |